RESMED INC

RMD - CIK 0000943819

Market cap$28.08 B

Rank#490

SEC filings2,518

RESMED INC trades as RMD and has a market capitalization of $28.08 B, making it the #490 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $5.15B, up 9.8% from the prior year and net income of $1.40B. This page tracks RESMED INC through 2,518 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Revenue (latest FY)$5.15BFY 2025

Net income (latest FY)$1.40BFY 2025

Operating cash flow (latest FY)$1.75BFY 2025

Total assets (latest FY)$8.17BFY 2025

Gross margin59.4%latest FY

Net margin27.2%latest FY

Financial performance

Over the last 9 fiscal years RESMED INC's revenue grew from $1.84B to $5.15B, a compound annual growth rate of 12.1%. Net profit margin expanded from 19.2% to 27.2% over the same period - every figure below comes from the company's audited annual filings.

RMD annual revenueView details

Key statistics

Market cap: $28.08 B
Share price (derived)market cap / shares outstanding: $193.57
P/E ratio (trailing FY): 20.0
EPS (diluted)FY 2025: $9.51
Shares outstandingas of 2026-04-27: 0.15B
Total equityas of 2026-03-31: $6.49B
Return on equity: 21.6%
Long-term debtas of 2026-03-31: $404.17M

Latest filings

Filing	Type	Filed
Insider trade	4	2026-05-11
Insider sale notice	144	2026-05-07
New insider ownership	3	2026-05-04
Insider trade	4	2026-05-04
Quarterly report	10-Q	2026-05-01
Major company event	8-K	2026-04-30
Major company event	8-K	2026-04-30
SCHEDULE 13G	-	2026-04-29

Browse the full filing history (2,518 filings)

Recent press releases

Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference :: ResMed Inc. (RMD)2026-05-19
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026 :: ResMed Inc. (RMD)2026-04-30
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026
Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026 :: ResMed Inc. (RMD)2026-04-30
Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026 :: ResMed Inc. (RMD)2026-01-29
Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026 :: ResMed Inc. (RMD)2026-01-29
Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.

Similar companies

The largest companies sharing RESMED INC's SEC industry classification (surgical & medical instruments & apparatus).

SYKStryker Corporation$117.82 B RMD vs SYK

MMM3M Company$81.87 B RMD vs MMM

BSXBoston Scientific Corporation$71.33 B RMD vs BSX

MDLNMedline Inc.$49.12 B RMD vs MDLN

BDXBecton, Dickinson and Company$41.03 B RMD vs BDX

Frequently asked questions

What is RESMED INC's market cap?

RESMED INC (RMD) has a market capitalization of $28.08 B as of 2026-06-10, ranking #490 among US-listed companies.

How much revenue does RESMED INC make?

RESMED INC reported revenue of $5.15B for fiscal year 2025, an increase of 9.8% year over year.

Is RESMED INC profitable?

Yes. RESMED INC reported net income of $1.40B in its latest fiscal year.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.